Summary: S.1391 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for S.1391. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (05/09/2019)

Fair Accountability and Innovative Research Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.